Share

October 2015; 5 (5) Drugs and Devices

The application of optical coherence tomography in neurologic diseases

Ramiro S. Maldonado, Pradeep Mettu, Mays El-Dairi, M. Tariq Bhatti
First published September 17, 2015, DOI: https://doi.org/10.1212/CPJ.0000000000000187
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
316

Share

Article Information

vol. 5 no. 5 460-469
DOI: 
https://doi.org/10.1212/CPJ.0000000000000187
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published September 17, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Ramiro S. Maldonado, MD*,
    2. Pradeep Mettu, MD*,
    3. Mays El-Dairi, MD and
    4. M. Tariq Bhatti, MD
  1. Ramiro S. Maldonado, MD*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Pradeep Mettu, MD*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Mays El-Dairi, MD and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Prana pharmaceuticals consultant

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Received grant from Knight templar July 2015. Unrelated to work submitted

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. M. Tariq Bhatti, MD
    5. Scientific Advisory Boards:

    1. 1. Novartis

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. 1. Novartis

    Editorial Boards:

    1. Journal of Neuro-Ophthalmology, editorial board member, 2015

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Novartis

    Speakers' Bureaus:

    1. Novartis

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Ophthalmology (RSM, PM, ME-D, MTB), Duke University Eye Center; and Department of Neurology (MTB), Duke University School of Medicine, Durham, NC.
  1. Correspondence to:
    tariq.bhatti{at}duke.edu
View Full Text

Article usage

Article usage: September 2015 to February 2023

AbstractFullPdfSource
Sep 2015102012Highwire
Oct 20154832560Highwire
Nov 20153101132Highwire
Dec 2015182418Highwire
Jan 20169506Highwire
Feb 20166616Highwire
Mar 201610447Highwire
Apr 20167003Highwire
May 201611846Highwire
Jun 201612005Highwire
Jul 20164801Highwire
Aug 20164963Highwire
Sep 20167400Highwire
Oct 20165501Highwire
Nov 20165601Highwire
Dec 20164101Highwire
Jan 20175504Highwire
Feb 20175327Highwire
Mar 20178443Highwire
Apr 20175804Highwire
May 20175303Highwire
Jun 20175904Highwire
Jul 20174810Highwire
Aug 20175606Highwire
Sep 20173700Highwire
Oct 20173301Highwire
Nov 20174206Highwire
Dec 201741612Highwire
Jan 20186101Highwire
Feb 20184321Highwire
Mar 20185000Highwire
Apr 20185010Highwire
Apr 2018265pmc
May 20183943Highwire
Jun 20184300Highwire
Jun 201861516pmc
Jul 20183822Highwire
Aug 20184321Highwire
Aug 2018183022pmc
Sep 20184521Highwire
Oct 20183122Highwire
Nov 20183621Highwire
Dec 20184700Highwire
Jan 20194300Highwire
Feb 20193820Highwire
Mar 20193821Highwire
Apr 20193030Highwire
May 20194320Highwire
Jun 20193531Highwire
Jul 20192410Highwire
Aug 20192024Highwire
Sep 20192332Highwire
Oct 20194223Highwire
Nov 20192622Highwire
Dec 20193330Highwire
Jan 20203745Highwire
Feb 20202831Highwire
Mar 20203092Highwire
Apr 20202710Highwire
May 20203620Highwire
Jun 20202010Highwire
Jul 20202110Highwire
Aug 20202020Highwire
Sep 20202510Highwire
Oct 20201530Highwire
Nov 20203531Highwire
Dec 20204120Highwire
Jan 20212800Highwire
Feb 20212682Highwire
Mar 20214961Highwire
Apr 20211120Highwire
May 20211630Highwire
Jun 20215520Highwire
Jul 20213541Highwire
Aug 20214351Highwire
Sep 20212021Highwire
Oct 20212220Highwire
Nov 20211420Highwire
Dec 20213702Highwire
Jan 20226610Highwire
Feb 20223863Highwire
Mar 20223832Highwire
Apr 20222300Highwire
May 20222642Highwire
Jun 20224200Highwire
Jul 20221662Highwire
Aug 20222120Highwire
Sep 202238101Highwire
Oct 20223361Highwire
Nov 20227941Highwire
Dec 20227161Highwire
Jan 20233462Highwire
Feb 20233144Highwire

The Nerve!: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles